Shea C. Harrelson, PA-C and Scotty Branch, Co-Founders
The announcement was made at SCBIO 2021, South Carolina's life sciences industry annual conference.
FREMONT, CA: Vikor Scientific, a leading molecular diagnostics company with a rapidly expanding nationwide footprint, has declared a strategic investment in California-based Quantgene to boost the commercialization of Quantgene's flagship product, Serenity. Serenity offers world-leading accuracy in precision genomics as well as AI-enabled personalized preventative care. The announcement was made at SCBIO 2021, South Carolina's life sciences industry annual conference.
Quantgene's Serenity combines sophisticated next-generation sequencing with proprietary cloud and AI technology to unveil deeper and more meaningful health insights earlier.
The combination of these components enables the system to detect, flag, and monitor disease and disease risk at earlier stages. Early intervention for fatal conditions like cancer is critical to assuring better treatment response and long-term outcomes. This is a crucial advancement in marrying medicine and technology to make sure the company understands its mission of extending the average lifespan of members by a decade within a decade.
South Carolina-based Vikor Scientific is a market leader in providing targeted molecular diagnostics that can improve economic and clinical outcomes. Headquartered in Charleston, S.C., Vikor anchors the WestEdge Life Sciences Campus close to the Medical University of South Carolina and is approaching 400 employees across the nation. The announcement was unveiled at SCBIO 2021, the acclaimed national conference of South Carolina's life sciences industry, which draws industry leaders from all over the globe.
Shea Harrelson, the co-founder of Vikor Scientific, stated, "In Quantgene, Vikor saw a compelling opportunity to support the commercialization of advanced genomics in the service of preventative care and positively impacting the course of many chronic diseases, starting with cancer. This partnership aligns perfectly with our mission as a company - to improve patient outcomes and prevent unnecessary healthcare costs and delays in treatment by improving diagnostic accuracy, reducing turnaround time and personalizing treatment options."